Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines - González Muñoz, Cynthia; Álvarez Arzola, Rydell; Calvo Pérez, Adanays; Frometa Campanón, Milagro de la Caridad; Hernández Casaña, Patricia; Fernández-Calienes Valdés, Aymé; Lorenzo-Luaces, Patricia; Mazorra Herrera, Zaima; Crombet Ramos, Tania; Labrada Mon, Mayrel (Frontiers in Immunology, 2025)